This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Shelley Force Aldred, Ph.D.
Co-Founder & CEO at Rondo Therapeutics


Shelley Force Aldred is CEO and Co-founder of Rondo Therapeutics, an emerging biopharmaceutical company developing bispecific therapeutic antibodies that enable controlled activation of the immune system to fight cancer. Previously, Dr. Force Aldred was a member of TeneoBio’s founding team where she led preclinical development for the company’s CD3 T-cell engager platform which ultimately generated $1.5B in up-front payments through partnerships and an acquisition by Amgen. Early in her career, Dr. Force Aldred earned a Ph.D. in Genetics from Stanford and developed a passion for starting companies when she co-founded SwitchGear Genomics which later sold to Active Motif.

Agenda Sessions

  • Chairman’s Remarks